Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is focused on discovering and developing novel drugs to treat cancer and inborn errors of metabolism, or IEMs, which are rare genetic metabolic diseases, through scientific leadership in the field of cellular metabolism. In...
Medical Director/Senior Medical Director
Responsible for the advancement of development programs, coordinate and monitor the clinical studies ensuring compliance with ICH/GCP and federal regulations.
• Provide medical and...
Adamas Pharmaceuticals, Inc.
The Director, Medical Affairs is responsible for overseeing the direction, planning, execution and interpretation of scientific data to advance Adamas’ programs, creates and executes training initiatives, and manages vendor relationships in alignment...
This position will design, plan and execute clinical trials, from leading the development of clinical plans to driving through clinical studies. You will identify needs, contingencies and operational plans, while also ensuring...
Rigel Pharmaceuticals, Inc.
South San Francisco,
Rigel is a clinical-stage biotechnology company dedicated to the discovery and development of novel, targeted drugs in the therapeutic areas of immunology, oncology and immuno-oncology. Rigel's pioneering research focuses on signaling...
The Senior Medical Science Liaison (Senior MSL) role is a field-based position and reports to the Director, Medial Science Liaisons (Americas). The Senior MSL provides fair balanced, objective, scientific information and education about...
Ultragenyx Pharmaceutical Inc.
Why Join Us?
Ultragenyx is a clinical stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. Founded...
Portola Pharmaceuticals, Inc.
South San Francisco,
Portola Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who currently have limited or no...